300194 福安药业
已收盘 06-08 15:00:00
资讯
新帖
简况
福安药业:公司目前没有在研发领域有AI技术布局、储备或落地应用
证券之星 · 06-04
福安药业:公司目前没有在研发领域有AI技术布局、储备或落地应用
福安药业(300194.SZ)子公司二氮嗪原料药获得FDA注册批准通知书
智通财经 · 06-03
福安药业(300194.SZ)子公司二氮嗪原料药获得FDA注册批准通知书
股市必读:福安药业(300194)6月1日董秘有最新回复
证券之星 · 06-02
股市必读:福安药业(300194)6月1日董秘有最新回复
福安药业:截止5月29日,公司股东户数为36087户
证券之星 · 06-01
福安药业:截止5月29日,公司股东户数为36087户
福安药业最新公告:子公司收到米库氯铵注射液等药品注册证书及补充申请批准通知书
证券之星 · 05-22
福安药业最新公告:子公司收到米库氯铵注射液等药品注册证书及补充申请批准通知书
福安药业:截止5月20日,公司股东户数为36449户
证券之星 · 05-22
福安药业:截止5月20日,公司股东户数为36449户
福安药业(300194)披露2025年年度权益分派实施公告,5月21日股价下跌1.52%
证券之星 · 05-21
福安药业(300194)披露2025年年度权益分派实施公告,5月21日股价下跌1.52%
福安药业(300194)披露2025年年度股东会决议公告,5月20日股价下跌1.5%
证券之星 · 05-20
福安药业(300194)披露2025年年度股东会决议公告,5月20日股价下跌1.5%
福安药业:目前公司所处的行业受政策影响,市场竞争激烈,利润空间承压,整体业绩下降
证券之星 · 05-19
福安药业:目前公司所处的行业受政策影响,市场竞争激烈,利润空间承压,整体业绩下降
股市必读:福安药业(300194)股东户数3.71万户,较上期减少0.23%
证券之星 · 05-13
股市必读:福安药业(300194)股东户数3.71万户,较上期减少0.23%
福安药业:截止5月8日,公司股东户数为37090户
证券之星 · 05-12
福安药业:截止5月8日,公司股东户数为37090户
股市必读:福安药业(300194)5月8日董秘有最新回复
证券之星 · 05-11
股市必读:福安药业(300194)5月8日董秘有最新回复
福安药业:公司2026一季报经营活动产生的现金流量净额同比增长
证券之星 · 05-07
福安药业:公司2026一季报经营活动产生的现金流量净额同比增长
福安药业:公司子公司生产的化学原料药主要用于化学药品制剂的生产
证券之星 · 04-29
福安药业:公司子公司生产的化学原料药主要用于化学药品制剂的生产
福安药业(300194)披露2026年一季度报告,4月27日股价上涨2.21%
证券之星 · 04-27
福安药业(300194)披露2026年一季度报告,4月27日股价上涨2.21%
图解福安药业年报:第四季度单季净利润同比下降310.05%
证券之星 · 04-26
图解福安药业年报:第四季度单季净利润同比下降310.05%
福安药业:子公司重庆庆余堂有生产销售精神药品
证券之星 · 04-24
福安药业:子公司重庆庆余堂有生产销售精神药品
福安药业:公司子公司重庆庆余堂目前持有苏州优诺金公司20.8%股权
证券之星 · 04-21
福安药业:公司子公司重庆庆余堂目前持有苏州优诺金公司20.8%股权
股市必读:福安药业(300194)4月17日董秘有最新回复
证券之星 · 04-20
股市必读:福安药业(300194)4月17日董秘有最新回复
福安药业(300194.SZ)子公司取得一项药品注册证书
智通财经 · 04-13
福安药业(300194.SZ)子公司取得一项药品注册证书
加载更多
公司概况
公司名称:
福安药业(集团)股份有限公司
所属行业:
医药制造业
上市日期:
2011-03-22
主营业务:
福安药业(集团)股份有限公司的主营业务是化学药品的研发、生产、销售。公司的主要产品是庆大霉素、头孢唑肟钠、头孢美唑钠、拉氧头孢钠、头孢他啶、枸橼酸托瑞米芬片(制剂)、盐酸昂丹司琼(原料药、制剂)、盐酸格拉司琼(原料药、制剂)、多索茶碱(原料药、制剂)、尼麦角林胶囊、舒林酸片、谷胱甘肽、注射用甲泼尼龙琥珀酸钠、注射用氢化可的松琥珀酸钠、盐酸乐卡地平。公司多次荣获“中国医药工业百强企业”“中国药品研发综合实力前100强”“中国化药研发实力50强”等荣誉称号。
发行价格:
41.88
{"stockData":{"symbol":"300194","market":"SZ","secType":"STK","nameCN":"福安药业","latestPrice":3.62,"timestamp":1780902222000,"preClose":3.73,"halted":0,"volume":9412163,"delay":0,"changeRate":-0.0295,"floatShares":968000000,"shares":1190000000,"eps":0.0529,"marketStatus":"已收盘","change":-0.11,"latestTime":"06-08 15:00:00","open":3.68,"high":3.72,"low":3.58,"amount":34315200,"amplitude":0.0375,"askPrice":3.63,"askSize":664,"bidPrice":3.62,"bidSize":398,"shortable":0,"etf":0,"ttmEps":0.0529,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780968600000},"marketStatusCode":5,"adr":0,"adjPreClose":3.73,"symbolType":"stock","openAndCloseTimeList":[[1780882200000,1780889400000],[1780894800000,1780902000000]],"highLimit":4.1,"lowLimit":3.36,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1189712382,"isCdr":false,"pbRate":1,"roa":"--","peRate":68.431002,"roe":"1.25%","epsLYR":0.06,"committee":-0.230141,"marketValue":4307000000,"turnoverRate":0.0097,"status":1,"floatMarketCap":3505000000},"requestUrl":"/m/hq/s/300194/","defaultTab":"news","newsList":[{"id":"2640503061","title":"福安药业:公司目前没有在研发领域有AI技术布局、储备或落地应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2640503061","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640503061?lang=zh_cn&edition=full","pubTime":"2026-06-04 20:48","pubTimestamp":1780577302,"startTime":"0","endTime":"0","summary":"公司目前没有在研发领域有AI技术布局、储备或落地应用,也没有具体的运用AI技术进行研发升级与降本增效计划,公司将对相关技术前沿与应用动态保持关注,结合公司具体实际情况,选择符合自身需求的研发技术和战略,谢谢!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400039287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","300194","BK0132","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640221974","title":"福安药业(300194.SZ)子公司二氮嗪原料药获得FDA注册批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2640221974","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640221974?lang=zh_cn&edition=full","pubTime":"2026-06-03 15:56","pubTimestamp":1780473383,"startTime":"0","endTime":"0","summary":"智通财经APP讯,福安药业(300194.SZ)发布公告,公司全资子公司广安凯特制药有限公司(简称“广安凯特”)于近日收到美国食品药品监督管理局(简称“FDA”)签发的二氮嗪原料药注册批准通知书。二氮嗪(Diazoxide)是一种快速降压药及胰岛素分泌抑制剂,主要用于高血压危象和胰岛素瘤相关低血糖症的治疗。它通过激活血管平滑肌的钾离子通道,扩张血管降低血压,同时抑制胰腺β细胞释放胰岛素,调节血糖水平。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449569.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","300194","BK0239","BK0060","BK4588","BK0028","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640667399","title":"股市必读:福安药业(300194)6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640667399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640667399?lang=zh_cn&edition=full","pubTime":"2026-06-02 01:58","pubTimestamp":1780336693,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘,福安药业报收于3.9元,上涨2.09%,换手率1.17%,成交量11.34万手,成交额4360.0万元。董秘最新回复投资者: 尊敬的董秘,您好!今天是5月份最后一个交易日,敬请发布截至5月底公司的股东户数信息。董秘: 截止5月29日,公司股东户数为36087户,谢谢!当日关注点来自交易信息汇总:6月1日主力资金净流入561.6万元,显示主力对个股短期关注度提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200001535.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0028","300194","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640346469","title":"福安药业:截止5月29日,公司股东户数为36087户","url":"https://stock-news.laohu8.com/highlight/detail?id=2640346469","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640346469?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:15","pubTimestamp":1780301756,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)06月01日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,您好!今天是5月份最后一个交易日,敬请发布截至5月底公司的股东户数信息。谢谢!祝周末愉快!福安药业回复:截止5月29日,公司股东户数为36087户,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100022573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0060","BK0132","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637392427","title":"福安药业最新公告:子公司收到米库氯铵注射液等药品注册证书及补充申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2637392427","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637392427?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:57","pubTimestamp":1779440254,"startTime":"0","endTime":"0","summary":"福安药业(300194.SZ)公告称,公司全资子公司庆余堂近日收到国家药监局签发的药品注册证书及补充申请批准通知书。其中,米库氯铵注射液(化药4类,规格5ml:10mg、10ml:20mg)和聚多卡醇注射液(化药4类,规格2ml:10mg、2ml:20mg、2ml:60mg)获批注册;注射用头孢西丁钠(规格2.0g、1.0g、0.5g)的上市许可持有人由浙江惠迪森药业变更为庆余堂。上述药品的获批将进一步丰富子公司产品线,提升市场竞争力,但生产销售及业绩影响存在不确定性。以上内容为证券之星据公开信息整理,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200030674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0132","BK0060","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637362069","title":"福安药业:截止5月20日,公司股东户数为36449户","url":"https://stock-news.laohu8.com/highlight/detail?id=2637362069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637362069?lang=zh_cn&edition=full","pubTime":"2026-05-22 11:36","pubTimestamp":1779420976,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)05月21日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,您好!敬请发布截至今天5月中旬末公司股东户数信息。谢谢!致礼!福安药业回复:截止5月20日,公司股东户数为36449户,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200019403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300194","BK0132","BK0028","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637438212","title":"福安药业(300194)披露2025年年度权益分派实施公告,5月21日股价下跌1.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637438212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637438212?lang=zh_cn&edition=full","pubTime":"2026-05-21 18:26","pubTimestamp":1779359177,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘,福安药业报收于3.89元,较前一交易日下跌1.52%,最新总市值为46.28亿元。该股当日开盘3.96元,最高3.99元,最低3.89元,成交额达3300.34万元,换手率为0.86%。近日,福安药业(集团)股份有限公司发布《2025年年度权益分派实施公告》。公告显示,公司2025年年度权益分派方案已获2026年5月19日召开的年度股东会审议通过。股权登记日为2026年5月27日,除权除息日为2026年5月28日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100036482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","300194","BK0060","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636843823","title":"福安药业(300194)披露2025年年度股东会决议公告,5月20日股价下跌1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636843823","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636843823?lang=zh_cn&edition=full","pubTime":"2026-05-20 17:55","pubTimestamp":1779270915,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘,福安药业报收于3.95元,较前一交易日下跌1.5%,最新总市值为46.99亿元。该股当日开盘4.0元,最高4.0元,最低3.93元,成交额达2331.08万元,换手率为0.61%。福安药业于近日披露《2025年年度股东会决议公告》。所有议案均获通过,中小投资者表决单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000034509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0028","300194","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636588183","title":"福安药业:目前公司所处的行业受政策影响,市场竞争激烈,利润空间承压,整体业绩下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2636588183","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636588183?lang=zh_cn&edition=full","pubTime":"2026-05-19 11:34","pubTimestamp":1779161663,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业05月19日在投资者关系平台上答复投资者关心的问题。目前公司所处的行业受政策影响,市场竞争激烈,利润空间承压,整体业绩下降。公司将继续积极适应政策变化,采取有效措施降本增效,努力保持生产经营稳定,改善经营业绩。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900019497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0060","BK0132","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635249996","title":"股市必读:福安药业(300194)股东户数3.71万户,较上期减少0.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635249996","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635249996?lang=zh_cn&edition=full","pubTime":"2026-05-13 00:59","pubTimestamp":1778605150,"startTime":"0","endTime":"0","summary":"截至2026年5月12日收盘,福安药业报收于4.1元,下跌1.91%,换手率1.44%,成交量13.94万手,成交额5754.37万元。来自股本股东变化:截至5月8日股东户数环比下降0.23%,户均持股上升至3.21万股,筹码略有集中。股本股东变化股东户数变动截至2026年5月8日,福安药业股东户数为3.71万户,较4月30日减少87.0户,减幅0.23%。户均持股数量升至3.21万股,户均持股市值为13.25万元。董秘: 截止5月8日,公司股东户数为37090户,谢谢!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300001478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0132","BK0239","300194","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634426820","title":"福安药业:截止5月8日,公司股东户数为37090户","url":"https://stock-news.laohu8.com/highlight/detail?id=2634426820","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634426820?lang=zh_cn&edition=full","pubTime":"2026-05-12 11:36","pubTimestamp":1778556997,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)05月12日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,您好!敬请发布截至5月上旬末公司股东户数信息。谢谢!致礼!福安药业回复:截止5月8日,公司股东户数为37090户,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200016903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0028","300194","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634097426","title":"股市必读:福安药业(300194)5月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2634097426","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634097426?lang=zh_cn&edition=full","pubTime":"2026-05-11 03:37","pubTimestamp":1778441830,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,福安药业报收于4.13元,上涨0.49%,换手率0.92%,成交量8.95万手,成交额3688.4万元。投资者: 此前关于F351羟尼酮与公司关联的提问,信息来源有误,请董秘无需回答该问题,感谢。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100001669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300194","BK0028","BK0132","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633219069","title":"福安药业:公司2026一季报经营活动产生的现金流量净额同比增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2633219069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633219069?lang=zh_cn&edition=full","pubTime":"2026-05-07 15:07","pubTimestamp":1778137635,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)05月07日在投资者关系平台上答复投资者关心的问题。投资者提问:公司一季报的经营现金流改善是什么原因?以后会持续吗福安药业回复:您好,公司2026一季报经营活动产生的现金流量净额同比增长主要系与去年同期相比,本报告期购买商品、接受劳务支付的现金减少,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700018643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0060","BK0132","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631553263","title":"福安药业:公司子公司生产的化学原料药主要用于化学药品制剂的生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2631553263","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631553263?lang=zh_cn&edition=full","pubTime":"2026-04-29 08:42","pubTimestamp":1777423349,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)04月28日在投资者关系平台上答复投资者关心的问题。投资者提问:公司的原料药有没有应用在医药行业以外的领域?福安药业回复:您好,目前公司子公司生产的化学原料药主要用于化学药品制剂的生产,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900027086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","300194","BK0239","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630036057","title":"福安药业(300194)披露2026年一季度报告,4月27日股价上涨2.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630036057","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630036057?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:36","pubTimestamp":1777286177,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘,福安药业报收于4.16元,较前一交易日上涨2.21%,最新总市值为49.49亿元。该股当日开盘4.07元,最高4.16元,最低4.05元,成交额达5468.5万元,换手率为1.37%。福安药业于2026年4月27日披露《2026年一季度报告》。报告显示,公司2026年第一季度实现营业收入407,493,108.61元,同比下降12.87%;归属于上市公司股东的净利润54,916,269.30元,同比下降20.47%;扣除非经常性损益后的净利润48,649,638.11元,同比下降25.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700035009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300194","BK0060","BK0028","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630381167","title":"图解福安药业年报:第四季度单季净利润同比下降310.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630381167","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630381167?lang=zh_cn&edition=full","pubTime":"2026-04-26 16:44","pubTimestamp":1777193050,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业2025年年报显示,当年度公司主营收入17.38亿元,同比下降27.31%;归母净利润7699.71万元,同比下降72.48%;扣非净利润5964.5万元,同比下降76.93%;其中2025年第四季度,公司单季度主营收入4.23亿元,同比上升6.75%;单季度归母净利润-8926.56万元,同比下降310.05%;单季度扣非净利润-8885.23万元,同比下降262.75%;负债率24.26%,投资收益1.38亿元,财务费用-731.28万元,毛利率36.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600010214.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629815251","title":"福安药业:子公司重庆庆余堂有生产销售精神药品","url":"https://stock-news.laohu8.com/highlight/detail?id=2629815251","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629815251?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:06","pubTimestamp":1777017973,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)04月24日在投资者关系平台上答复投资者关心的问题。投资者提问:公司产品有没有麻醉药品和精神药品定点生产企业资质?福安药业回复:公司子公司重庆庆余堂有生产销售精神药品,具备相关药品生产的企业资质,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400047835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0060","BK0132","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629850680","title":"福安药业:公司子公司重庆庆余堂目前持有苏州优诺金公司20.8%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2629850680","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629850680?lang=zh_cn&edition=full","pubTime":"2026-04-21 15:54","pubTimestamp":1776758049,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)04月21日在投资者关系平台上答复投资者关心的问题。投资者提问:公司参股的优诺金公司年初有一次融资,是不是有新股东看好优诺金,公司在里面的股权比例有没有变化?福安药业回复:公司子公司重庆庆余堂目前持有苏州优诺金公司20.8%股权,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100033816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0028","300194","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628476795","title":"股市必读:福安药业(300194)4月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2628476795","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628476795?lang=zh_cn&edition=full","pubTime":"2026-04-20 04:24","pubTimestamp":1776630249,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘,福安药业报收于4.18元,下跌1.65%,换手率1.51%,成交量14.63万手,成交额6117.46万元。董秘最新回复投资者: 公司的首仿产品是怎么销售的?当日关注点来自交易信息汇总:4月17日主力资金净流出622.82万元,显示主力短期减持动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000001351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","BK0239","300194","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627859438","title":"福安药业(300194.SZ)子公司取得一项药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2627859438","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627859438?lang=zh_cn&edition=full","pubTime":"2026-04-13 15:48","pubTimestamp":1776066496,"startTime":"0","endTime":"0","summary":"智通财经APP讯,福安药业(300194.SZ)公告,公司全资子公司福安药业集团宁波天衡制药有限公司(简称“天衡药业”)于近日收到国家药品监督管理局签发的药品注册证书,药品名称为吗啉硝唑氯化钠注射液。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0132","300194","BK0028","BK0060"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780946196505,"stockEarnings":[{"period":"1week","weight":-0.0718},{"period":"1month","weight":-0.1119},{"period":"3month","weight":-0.151},{"period":"6month","weight":-0.1957},{"period":"1year","weight":-0.1248},{"period":"ytd","weight":-0.172}],"compareEarnings":[{"period":"1week","weight":-0.0242},{"period":"1month","weight":-0.0528},{"period":"3month","weight":-0.0397},{"period":"6month","weight":0.0151},{"period":"1year","weight":0.1695},{"period":"ytd","weight":-0.0024}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"福安药业(集团)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"36087人(较上一季度减少0.99%)","perCapita":"26833股","listingDate":"2011-03-22","address":"重庆市长寿区化南一路1号","registeredCapital":"118971万元","survey":" 福安药业(集团)股份有限公司的主营业务是化学药品的研发、生产、销售。公司的主要产品是庆大霉素、头孢唑肟钠、头孢美唑钠、拉氧头孢钠、头孢他啶、枸橼酸托瑞米芬片(制剂)、盐酸昂丹司琼(原料药、制剂)、盐酸格拉司琼(原料药、制剂)、多索茶碱(原料药、制剂)、尼麦角林胶囊、舒林酸片、谷胱甘肽、注射用甲泼尼龙琥珀酸钠、注射用氢化可的松琥珀酸钠、盐酸乐卡地平。公司多次荣获“中国医药工业百强企业”“中国药品研发综合实力前100强”“中国化药研发实力50强”等荣誉称号。","listedPrice":41.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福安药业,300194,福安药业股票,福安药业股票老虎,福安药业股票老虎国际,福安药业行情,福安药业股票行情,福安药业股价,福安药业股市,福安药业股票价格,福安药业股票交易,福安药业股票购买,福安药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}